OXALTERO 50MG/25ML INJECTION

OXALTERO 50MG/25ML INJECTION is used to treat colon and rectal cancer. It belongs to the group of medications called Platinum-based antineoplastic agents.

Patients with severe kidney problems, low blood cells, tingling, and numbness in the fingers and breastfeeding mothers should not use OXALTERO 50MG/25ML INJECTION. It is also not recommended for patients who are allergic to OXALTERO 50MG/25ML INJECTION and its ingredients.

It is unsafe to become a father while on treatment and six months after treatment. Hence, effective contraceptives must be used during this time. Before receiving OXALTERO 50MG/25ML INJECTION treatment, male patients should get advice on sperm conservation.

Treatment with OXALTERO 50MG/25ML INJECTION may raise the risk of dizziness, nausea, vomiting, vision problems, and other neurological symptoms that affect walking and balance. Therefore, when receiving OXALTERO 50MG/25ML INJECTION treatment, avoid operating heavy machinery and driving.

No, you should not get vaccinated with "live" or "attenuated" vaccinations, like the yellow fever vaccine, as it may weaken the immune system and cause severe adverse effects. Hence, without consulting your healthcare provider, this medication should not be taken with any vaccinations.

No, Pregnant women should avoid handling OXALTERO 50MG/25ML INJECTION as it contains cytotoxic agents.

There are no known interactions of OXALTERO 50MG/25ML INJECTION with other drugs.

It is suggested that women should use effective birth control for at least four weeks before starting and during treatment with OXALTERO 50MG/25ML INJECTION. Male patients are advised to use effective contraception during therapy and six months after treatment to avoid fathering children. Before receiving OXALTERO 50MG/25ML INJECTION treatment, male patients should get advice on sperm conservation. Pregnant women should not use or handle this drug since it contains cytotoxic substances. This medication is handled exclusively by healthcare professionals who use sterile single-use gloves, protective masks, hats, and goggles. Vaccinations should be avoided when using this drug since they may cause serious side effects.

OXALIPLATIN is the molecule/combination used for making OXALTERO 50MG/25ML INJECTION.

In Oncology, OXALTERO 50MG/25ML INJECTION is prescribed for the treatment of cancer.